Primary Progressive Aphasia in Alzheimer’s Doesn’t Foretell Memory Loss MedPage Today Go to News Source
Eli Lilly’s Alzheimer’s drug shows promise. But will it succeed where so many drugs have failed? The Daily Briefing Go to News Source
Alzheimer’s patients are dying in record numbers as pandemic up-ends their lives Detroit Free Press Go to News Source
Seattle Startup Chases Alzheimer’s with $23 Million Series A BioSpace Go to News Source
Noncanonical transnitrosylation network contributes to synapse loss in Alzheimer’s disease – Science
Noncanonical transnitrosylation network contributes to synapse loss in Alzheimer’s disease Science Go to News Source
Opinion: New help and hop in federal Alzheimer’s legislation Juneau Empire Go to News Source
Eli Lilly says drug slowed Alzheimer’s decline in preliminary study STAT Go to News Source
Memory may be preserved in condition with brain changes similar to Alzheimer’s disease EurekAlert Go to News Source
Virtual theatre program to be delivered for Alzheimer’s patients Northwest Georgia News Go to News Source
Study Identifies Vulnerable Neurons in Alzheimer’s Disease Genetic Engineering & Biotechnology News Go to News Source